{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:25:08Z","timestamp":1793935508187,"version":"4.8.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.breast.2026.104932","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:49:30Z","timestamp":1790135370000},"page":"104932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Performance of large language models in ambiguous treatment scenarios of early breast cancer"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8953-5103","authenticated-orcid":false,"given":"Anton","family":"Oseledchyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter Paul","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kasenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9114","key":"10.1016\/j.breast.2026.104932_bib1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: an overview of the randomised trials. Early breast cancer trialists' collaborative group","volume":"351","year":"1998","journal-title":"Lancet (London, England)"},{"issue":"8","key":"10.1016\/j.breast.2026.104932_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198902233200802","article-title":"A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors","volume":"320","author":"Fisher","year":"1989","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.breast.2026.104932_bib3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.breast.2026.104932_bib4","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","article-title":"Trastuzumab emtansine for HER2-positive advanced breast cancer","volume":"367","author":"Verma","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.breast.2026.104932_bib5","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol : Off J Am Soc Clin Oncol"},{"issue":"15","key":"10.1016\/j.breast.2026.104932_bib6","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J Clin Oncol : Off J Am Soc Clin Oncol"},{"issue":"15_suppl","key":"10.1016\/j.breast.2026.104932_bib7","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.e18563","article-title":"Phase III randomized clinical trials global distribution and funding: trends and disparities","volume":"39","author":"Pinheiro","year":"2021","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.breast.2026.104932_bib8","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.ejca.2015.07.045","article-title":"Clinical trial spots for cancer patients by tumour type: the cancer trials portfolio at clinicaltrials.gov","volume":"51","author":"Prasad","year":"2015","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.breast.2026.104932_bib9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/annonc\/mdp403","article-title":"Global drug development in cancer: a cross-sectional study of clinical trial registries","volume":"21","author":"Seruga","year":"2010","journal-title":"Ann Oncol : Off J Eur Soc Med Oncol"},{"issue":"12","key":"10.1016\/j.breast.2026.104932_bib10","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.annonc.2025.09.007","article-title":"Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancer","volume":"36","author":"Burstein","year":"2025","journal-title":"Ann Oncol : Off J Eur Soc Med Oncol"},{"issue":"4","key":"10.1016\/j.breast.2026.104932_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000546080","article-title":"St. Gallen\/Vienna 2025 summary of key messages on therapy in early breast cancer from the 2025 St. Gallen international breast cancer conference","volume":"20","author":"Ditsch","year":"2025","journal-title":"Breast Care"},{"issue":"26","key":"10.1016\/j.breast.2026.104932_bib12","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1056\/NEJMp1303712","article-title":"From mindless to mindful practice--cognitive bias and clinical decision making","volume":"368","author":"Croskerry","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.breast.2026.104932_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12911-016-0377-1","article-title":"Cognitive biases associated with medical decisions: a systematic review","volume":"16","author":"Saposnik","year":"2016","journal-title":"BMC Med Inf Decis Making"},{"issue":"3","key":"10.1016\/j.breast.2026.104932_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/M20-5665","article-title":"Are financial payments from the pharmaceutical industry associated with physician prescribing? : a systematic review","volume":"174","author":"Mitchell","year":"2021","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.breast.2026.104932_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.breast.2026.104932_bib16","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41591-023-02448-8","article-title":"Large language models in medicine","volume":"29","author":"Thirunavukarasu","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.breast.2026.104932_bib17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s43856-025-01021-3","article-title":"Multi-model assurance analysis showing large language models are highly vulnerable to adversarial hallucination attacks during clinical decision support","volume":"5","author":"Omar","year":"2025","journal-title":"Commun Med"},{"key":"10.1016\/j.breast.2026.104932_bib18","doi-asserted-by":"crossref","DOI":"10.2196\/59823","article-title":"The clinicians' guide to large language models: a general perspective with a focus on hallucinations","volume":"14","author":"Roustan","year":"2025","journal-title":"Interact J Med Res"},{"issue":"9","key":"10.1016\/j.breast.2026.104932_bib19","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1038\/s41591-024-03097-1","article-title":"Evaluation and mitigation of the limitations of large language models in clinical decision-making","volume":"30","author":"Hager","year":"2024","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.breast.2026.104932_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4258\/hir.2025.31.2.114","article-title":"Large language models in medicine: clinical applications, technical challenges, and ethical considerations","volume":"31","author":"Jung","year":"2025","journal-title":"Healthc Inform Res"},{"key":"10.1016\/j.breast.2026.104932_bib21","series-title":"A language and environment for statistical computing","author":"Team","year":"2023"},{"issue":"9596","key":"10.1016\/j.breast.2026.104932_bib22","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet (London, England)"},{"issue":"11","key":"10.1016\/j.breast.2026.104932_bib23","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s42256-024-00922-7","article-title":"Guidelines for ethical use and acknowledgement of large language models in academic writing","volume":"6","author":"Porsdam Mann","year":"2024","journal-title":"Nat Mach Intell"},{"issue":"13","key":"10.1016\/j.breast.2026.104932_bib24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jama.2024.26886","article-title":"Adjuvant atezolizumab for early triple-negative breast cancer: the ALEXANDRA\/IMpassion030 randomized clinical trial","volume":"333","author":"Ignatiadis","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.breast.2026.104932_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.annonc.2024.10.015","article-title":"A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive\/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial","volume":"36","author":"Hortobagyi","year":"2025","journal-title":"Ann Oncol : Off J Eur Soc Med Oncol"},{"issue":"18_suppl","key":"10.1016\/j.breast.2026.104932_bib26","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2010.28.18_suppl.lba513","article-title":"ACOSOG Z1031: a randomized phase II trial comparing exemestane, letrozole, and anastrozole in postmenopausal women with clinical stage II\/III estrogen receptor-positive breast cancer","volume":"28","author":"Ellis","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2026.104932_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/jamaoncol.2023.6038","article-title":"Endocrine-sensitive disease rate in postmenopausal patients with estrogen Receptor-Rich\/ERBB2-Negative breast cancer receiving neoadjuvant anastrozole, fulvestrant, or their combination: a phase 3 randomized clinical trial","volume":"10","author":"Ma","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2026.104932_bib28","series-title":"NCCN clinical practice guidelines in oncology","year":"2025"},{"issue":"25","key":"10.1016\/j.breast.2026.104932_bib29","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.breast.2026.104932_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1470-2045(13)70589-8","article-title":"Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial","volume":"15","author":"Aebi","year":"2014","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104932_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(22)00694-5","article-title":"Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial","volume":"24","author":"Johnston","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2026.104932_bib32","doi-asserted-by":"crossref","DOI":"10.2196\/64963","article-title":"Comparing diagnostic accuracy of clinical professionals and large language models: systematic review and meta-analysis","volume":"13","author":"Shan","year":"2025","journal-title":"JMIR Med Inform"},{"issue":"1","key":"10.1016\/j.breast.2026.104932_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s43856-025-00781-2","article-title":"Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance","volume":"5","author":"Goh","year":"2025","journal-title":"Commun Med"},{"issue":"1","key":"10.1016\/j.breast.2026.104932_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18751-2","article-title":"Experimental evidence of effective human-AI collaboration in medical decision-making","volume":"12","author":"Reverberi","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.breast.2026.104932_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41746-025-01670-7","article-title":"A framework to assess clinical safety and hallucination rates of LLMs for medical text summarisation","volume":"8","author":"Asgari","year":"2025","journal-title":"npj Digit Med"},{"issue":"1","key":"10.1016\/j.breast.2026.104932_bib36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41746-025-01824-7","article-title":"Large language model integrations in cancer decision-making: a systematic review and meta-analysis","volume":"8","author":"Hao","year":"2025","journal-title":"npj Digit Med"},{"issue":"1","key":"10.1016\/j.breast.2026.104932_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00345-024-05423-1","article-title":"The interaction of structured data using openEHR and large language models for clinical decision support in prostate cancer","volume":"43","author":"Kaiser","year":"2025","journal-title":"World J Urol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626002420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626002420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:34:12Z","timestamp":1793932452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977626002420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"alternative-id":["S0960977626002420"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2026.104932","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of large language models in ambiguous treatment scenarios of early breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2026.104932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104932"}}